- Home
- ENVB vs EDBL Comparison
ENVB vs EDBL Comparison
Compare ENVB & EDBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENVB
- EDBL
- Stock Information
- Founded
- ENVB 1994
- EDBL 2020
- Country
- ENVB United States
- EDBL United States
- Employees
- ENVB N/A
- EDBL N/A
- Industry
- ENVB Biotechnology: Pharmaceutical Preparations
- EDBL Farming/Seeds/Milling
- Sector
- ENVB Health Care
- EDBL Consumer Staples
- Exchange
- ENVB Nasdaq
- EDBL Nasdaq
- Market Cap
- ENVB 3.2M
- EDBL 2.7M
- IPO Year
- ENVB N/A
- EDBL 2022
- Fundamental
- Price
- ENVB $1.28
- EDBL $2.25
- Analyst Decision
- ENVB Strong Buy
- EDBL
- Analyst Count
- ENVB 1
- EDBL 0
- Target Price
- ENVB $10.00
- EDBL N/A
- AVG Volume (30 Days)
- ENVB 42.6K
- EDBL 70.0K
- Earning Date
- ENVB 05-19-2025
- EDBL 05-15-2025
- Dividend Yield
- ENVB N/A
- EDBL N/A
- EPS Growth
- ENVB N/A
- EDBL N/A
- EPS
- ENVB N/A
- EDBL N/A
- Revenue
- ENVB N/A
- EDBL $13,857,000.00
- Revenue This Year
- ENVB N/A
- EDBL $29.56
- Revenue Next Year
- ENVB N/A
- EDBL $20.00
- P/E Ratio
- ENVB N/A
- EDBL N/A
- Revenue Growth
- ENVB N/A
- EDBL N/A
- 52 Week Low
- ENVB $1.01
- EDBL $1.82
- 52 Week High
- ENVB $222.75
- EDBL $230.00
- Technical
- Relative Strength Index (RSI)
- ENVB 31.74
- EDBL 49.19
- Support Level
- ENVB $1.23
- EDBL $1.87
- Resistance Level
- ENVB $1.40
- EDBL $2.40
- Average True Range (ATR)
- ENVB 0.09
- EDBL 0.14
- MACD
- ENVB 0.15
- EDBL 0.09
- Stochastic Oscillator
- ENVB 48.15
- EDBL 61.51
About ENVB Enveric Biosciences Inc.
Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.
About EDBL Edible Garden AG Incorporated
Edible Garden AG Inc is a next-generation controlled environment agriculture farming company. It uses traditional agricultural growing techniques together with technology to grow fresh, organic food, sustainably and safely while improving traceability. The company uses the controlled environment of traditional greenhouse structures, such as glass greenhouses together with hydroponic and vertical greenhouses to sustainably grow organic herbs and lettuces.